PTPN1 and diabetes mellitus: Furthermore, many studies have indicated that PTP1B expression is increased under many pathophysiological conditions such as inflammation, cancer, and diabetes, suggesting novel therapeutic implications for these PTP1B inhibitors in the treatment of such diseases [12].